ID   PRKX_HUMAN              Reviewed;         358 AA.
AC   P51817;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   15-MAR-2017, entry version 157.
DE   RecName: Full=cAMP-dependent protein kinase catalytic subunit PRKX;
DE            Short=PrKX;
DE            Short=Protein kinase X;
DE            Short=Protein kinase X-linked;
DE            Short=Serine/threonine-protein kinase PRKX;
DE            EC=2.7.11.1;
DE   AltName: Full=Protein kinase PKX1;
GN   Name=PRKX; Synonyms=PKX1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=7633447; DOI=10.1093/hmg/4.5.869;
RA   Klink A., Schiebel K., Winkelmann M., Rao E., Horsthemke B.,
RA   Luedecke H.-J., Claussen U., Scherer G., Rappold G.;
RT   "The human protein kinase gene PKX1 on Xp22.3 displays Xp/Yp homology
RT   and is a site of chromosomal instability.";
RL   Hum. Mol. Genet. 4:869-878(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Blood;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   CHROMOSOMAL TRANSLOCATION WITH PRKY.
RX   PubMed=9302280; DOI=10.1093/hmg/6.11.1985;
RA   Schiebel K., Winkelmann M., Mertz A., Xu X., Page D.C., Weil D.,
RA   Petit C., Rappold G.A.;
RT   "Abnormal XY interchange between a novel isolated protein kinase gene,
RT   PRKY, and its homologue, PRKX, accounts for one third of all (Y+)XX
RT   males and (Y-)XY females.";
RL   Hum. Mol. Genet. 6:1985-1989(1997).
RN   [4]
RP   FUNCTION IN MYELOID CELL DIFFERENTIATION, TISSUE SPECIFICITY, AND
RP   INDUCTION BY PMA.
RX   PubMed=9860982; DOI=10.1073/pnas.95.26.15412;
RA   Semizarov D., Glesne D., Laouar A., Schiebel K., Huberman E.;
RT   "A lineage-specific protein kinase crucial for myeloid maturation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:15412-15417(1998).
RN   [5]
RP   CATALYTIC ACTIVITY, KINETIC PARAMETERS, INTERACTION WITH PRKAR1A AND
RP   PKI, ENZYME REGULATION BY PRKAR1A AND PKI, SUBCELLULAR LOCATION, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=10026146; DOI=10.1074/jbc.274.9.5370;
RA   Zimmermann B., Chiorini J.A., Ma Y., Kotin R.M., Herberg F.W.;
RT   "PrKX is a novel catalytic subunit of the cAMP-dependent protein
RT   kinase regulated by the regulatory subunit type I.";
RL   J. Biol. Chem. 274:5370-5378(1999).
RN   [6]
RP   FUNCTION IN CREB-DEPENDENT TRANSCRIPTION, FUNCTION IN RENAL EPITHELIAL
RP   CELL MIGRATION AND TUBULOGENESIS, CATALYTIC ACTIVITY, KINETIC
RP   PARAMETERS, ENZYME REGULATION, SUBCELLULAR LOCATION, MUTAGENESIS OF
RP   LYS-78, AND DEVELOPMENTAL STAGE.
RX   PubMed=12082174; DOI=10.1073/pnas.132051799;
RA   Li X., Li H.P., Amsler K., Hyink D., Wilson P.D., Burrow C.R.;
RT   "PRKX, a phylogenetically and functionally distinct cAMP-dependent
RT   protein kinase, activates renal epithelial cell migration and
RT   morphogenesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:9260-9265(2002).
RN   [7]
RP   FUNCTION IN NEPHROGENESIS, MUTAGENESIS OF HIS-93 AND TRP-202, TISSUE
RP   SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=16236808; DOI=10.1681/ASN.2005030240;
RA   Li X., Hyink D.P., Polgar K., Gusella G.L., Wilson P.D., Burrow C.R.;
RT   "Protein kinase X activates ureteric bud branching morphogenesis in
RT   developing mouse metanephric kidney.";
RL   J. Am. Soc. Nephrol. 16:3543-3552(2005).
RN   [8]
RP   TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RX   PubMed=15879576; DOI=10.1369/jhc.4A6568.2005;
RA   Li W., Yu Z.X., Kotin R.M.;
RT   "Profiles of PrKX expression in developmental mouse embryo and human
RT   tissues.";
RL   J. Histochem. Cytochem. 53:1003-1009(2005).
RN   [9]
RP   FUNCTION IN MYELOID CELL DIFFERENTIATION, FUNCTION IN PHOSPHORYLATION
RP   OF SMAD6, AUTOPHOSPHORYLATION, SUBCELLULAR LOCATION, INTERACTION WITH
RP   GPKOW; PRKAR1A; SMAD6, AND INDUCTION BY PMA.
RX   PubMed=16491121; DOI=10.1038/sj.onc.1209436;
RA   Glesne D., Huberman E.;
RT   "Smad6 is a protein kinase X phosphorylation substrate and is required
RT   for HL-60 cell differentiation.";
RL   Oncogene 25:4086-4098(2006).
RN   [10]
RP   FUNCTION IN NEPHROGENESIS, FUNCTION IN PHOSPHORYLATION OF PKD1, AND
RP   INTERACTION WITH PKD1.
RX   PubMed=17980165; DOI=10.1016/j.bbadis.2007.09.003;
RA   Li X., Burrow C.R., Polgar K., Hyink D.P., Gusella G.L., Wilson P.D.;
RT   "Protein kinase X (PRKX) can rescue the effects of polycystic kidney
RT   disease-1 gene (PKD1) deficiency.";
RL   Biochim. Biophys. Acta 1782:1-9(2008).
RN   [11]
RP   FUNCTION IN NEPHROGENESIS, AND INTERACTION WITH PIN1.
RX   PubMed=19367327; DOI=10.1038/ki.2009.95;
RA   Li X., Hyink D.P., Radbill B., Sudol M., Zhang H., Zheleznova N.N.,
RA   Wilson P.D.;
RT   "Protein kinase-X interacts with Pin-1 and Polycystin-1 during mouse
RT   kidney development.";
RL   Kidney Int. 76:54-62(2009).
RN   [12]
RP   ENZYME REGULATION, INTERACTION WITH PRKAR1A AND PRKAR1B, AND
RP   MUTAGENESIS OF ARG-283.
RX   PubMed=20819953; DOI=10.1074/jbc.M110.155150;
RA   Diskar M., Zenn H.M., Kaupisch A., Kaufholz M., Brockmeyer S.,
RA   Sohmen D., Berrera M., Zaccolo M., Boshart M., Herberg F.W., Prinz A.;
RT   "Regulation of cAMP-dependent protein kinases: the human protein
RT   kinase X (PrKX) reveals the role of the catalytic subunit alphaH-
RT   alphaI loop.";
RL   J. Biol. Chem. 285:35910-35918(2010).
RN   [13]
RP   FUNCTION IN ANGIOGENESIS.
RX   PubMed=21684272; DOI=10.1016/j.ydbio.2011.05.673;
RA   Li X., Iomini C., Hyink D., Wilson P.D.;
RT   "PRKX critically regulates endothelial cell proliferation, migration,
RT   and vascular-like structure formation.";
RL   Dev. Biol. 356:475-485(2011).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
CC   -!- FUNCTION: Serine/threonine protein kinase regulated by and
CC       mediating cAMP signaling in cells. Acts through phosphorylation of
CC       downstream targets that may include CREB, SMAD6 and PKD1 and has
CC       multiple functions in cellular differentiation and epithelial
CC       morphogenesis. Regulates myeloid cell differentiation through
CC       SMAD6 phosphorylation. Involved in nephrogenesis by stimulating
CC       renal epithelial cell migration and tubulogenesis. Also involved
CC       in angiogenesis through stimulation of endothelial cell
CC       proliferation, migration and vascular-like structure formation.
CC       {ECO:0000269|PubMed:12082174, ECO:0000269|PubMed:16236808,
CC       ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:17980165,
CC       ECO:0000269|PubMed:19367327, ECO:0000269|PubMed:21684272,
CC       ECO:0000269|PubMed:9860982}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:12082174}.
CC   -!- ENZYME REGULATION: Binding of cAMP to the PRKAR1A or PRKAR1B
CC       regulatory subunits induces dissociation of the holoenzyme
CC       heterotetramer. The released monomeric PRKX is then active and
CC       able to phosphorylate its substrates.
CC       {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:12082174,
CC       ECO:0000269|PubMed:20819953}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=127 uM for ATP (in the presence of 10 mM magnesium chloride)
CC         {ECO:0000269|PubMed:10026146, ECO:0000269|PubMed:12082174};
CC         KM=58 uM for kemptide (in the presence of 10 mM magnesium
CC         chloride) {ECO:0000269|PubMed:10026146,
CC         ECO:0000269|PubMed:12082174};
CC         KM=6.7 uM for kemptide (in the presence of 1 uM Br-cAMP at 30
CC         degrees Celsius) {ECO:0000269|PubMed:10026146,
CC         ECO:0000269|PubMed:12082174};
CC   -!- SUBUNIT: Like other cAMP-dependent protein kinases, the inactive
CC       holoenzyme is probably composed of 2 PRKX catalytic subunits and a
CC       dimer of regulatory subunits. Interacts (cAMP-dependent)
CC       specifically with the regulatory subunits PRKAR1A and PRKAR1B.
CC       Compared to other cAMP-dependent serine/threonine protein kinases,
CC       does not interact with the 2 other PKA regulatory subunits PRKAR2A
CC       and PRKAR2B. Interacts with cAMP-dependent protein kinase
CC       inhibitor/PKI proteins; inhibits PRKX. Interacts with GPKOW.
CC       Interacts with SMAD6. Interacts with PKD1; involved in
CC       differentiation and controlled morphogenesis of the kidney.
CC       Interacts with PIN1 (via WW domain). {ECO:0000269|PubMed:10026146,
CC       ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:17980165,
CC       ECO:0000269|PubMed:19367327, ECO:0000269|PubMed:20819953}.
CC   -!- INTERACTION:
CC       Q92917:GPKOW; NbExp=2; IntAct=EBI-4302903, EBI-746309;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-4302903, EBI-352572;
CC       P10644:PRKAR1A; NbExp=2; IntAct=EBI-4302903, EBI-476431;
CC       O43541:SMAD6; NbExp=5; IntAct=EBI-4302903, EBI-976374;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus. Note=cAMP induces
CC       nuclear translocation.
CC   -!- TISSUE SPECIFICITY: Widely expressed (at protein level).
CC       Specifically expressed in blood by macrophages and granulocytes
CC       according to PubMed:9860982. {ECO:0000269|PubMed:15879576,
CC       ECO:0000269|PubMed:16236808, ECO:0000269|PubMed:7633447,
CC       ECO:0000269|PubMed:9860982}.
CC   -!- DEVELOPMENTAL STAGE: Expression is developmentally regulated being
CC       high and specific in a wide range of developing tissues including
CC       liver, kidney, brain and pancreas (at protein level).
CC       {ECO:0000269|PubMed:12082174, ECO:0000269|PubMed:15879576,
CC       ECO:0000269|PubMed:16236808}.
CC   -!- INDUCTION: Up-regulated by phorbol 12-myristate 13-acetate (PMA).
CC       {ECO:0000269|PubMed:16491121, ECO:0000269|PubMed:9860982}.
CC   -!- PTM: Phosphorylated; autophosphorylates in vitro.
CC   -!- DISEASE: Note=A chromosomal aberration involving PRKX is a cause
CC       of sex reversal disorder. Translocation t(X;Y)(p22;p11) with PRKY.
CC       Chromosomal translocations proximal to PRKY account for about 30%
CC       of the cases of sex reversal disorder in XX males and XY females.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. cAMP subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X85545; CAA59733.1; -; mRNA.
DR   EMBL; BC041073; AAH41073.1; -; mRNA.
DR   CCDS; CCDS14125.1; -.
DR   PIR; I38121; I38121.
DR   RefSeq; NP_005035.1; NM_005044.4.
DR   UniGene; Hs.390788; -.
DR   ProteinModelPortal; P51817; -.
DR   SMR; P51817; -.
DR   BioGrid; 111599; 7.
DR   IntAct; P51817; 6.
DR   STRING; 9606.ENSP00000262848; -.
DR   BindingDB; P51817; -.
DR   ChEMBL; CHEMBL5818; -.
DR   GuidetoPHARMACOLOGY; 2175; -.
DR   iPTMnet; P51817; -.
DR   PhosphoSitePlus; P51817; -.
DR   BioMuta; PRKX; -.
DR   DMDM; 1709648; -.
DR   EPD; P51817; -.
DR   MaxQB; P51817; -.
DR   PaxDb; P51817; -.
DR   PeptideAtlas; P51817; -.
DR   PRIDE; P51817; -.
DR   DNASU; 5613; -.
DR   Ensembl; ENST00000262848; ENSP00000262848; ENSG00000183943.
DR   GeneID; 5613; -.
DR   KEGG; hsa:5613; -.
DR   UCSC; uc010nde.4; human.
DR   CTD; 5613; -.
DR   DisGeNET; 5613; -.
DR   GeneCards; PRKX; -.
DR   H-InvDB; HIX0202211; -.
DR   HGNC; HGNC:9441; PRKX.
DR   HPA; HPA015324; -.
DR   MIM; 300083; gene.
DR   neXtProt; NX_P51817; -.
DR   OpenTargets; ENSG00000183943; -.
DR   PharmGKB; PA33786; -.
DR   eggNOG; KOG0616; Eukaryota.
DR   eggNOG; ENOG410XPQQ; LUCA.
DR   GeneTree; ENSGT00810000125385; -.
DR   HOGENOM; HOG000233033; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P51817; -.
DR   KO; K19584; -.
DR   OMA; HSVDWEA; -.
DR   OrthoDB; EOG091G10O8; -.
DR   PhylomeDB; P51817; -.
DR   TreeFam; TF313399; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   SABIO-RK; P51817; -.
DR   SignaLink; P51817; -.
DR   SIGNOR; P51817; -.
DR   GenomeRNAi; 5613; -.
DR   PRO; PR:P51817; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   Bgee; ENSG00000183943; -.
DR   CleanEx; HS_PRKX; -.
DR   ExpressionAtlas; P51817; baseline and differential.
DR   Genevisible; P51817; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004691; F:cAMP-dependent protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IMP:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IMP:UniProtKB.
DR   GO; GO:0031589; P:cell-substrate adhesion; IMP:UniProtKB.
DR   GO; GO:0043542; P:endothelial cell migration; IMP:UniProtKB.
DR   GO; GO:0001935; P:endothelial cell proliferation; IMP:UniProtKB.
DR   GO; GO:0060562; P:epithelial tube morphogenesis; IDA:UniProtKB.
DR   GO; GO:0060993; P:kidney morphogenesis; IDA:UniProtKB.
DR   GO; GO:0030099; P:myeloid cell differentiation; IDA:UniProtKB.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IDA:UniProtKB.
DR   GO; GO:0030334; P:regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:2000696; P:regulation of epithelial cell differentiation involved in kidney development; IDA:UniProtKB.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Angiogenesis; ATP-binding; cAMP;
KW   Chromosomal rearrangement; Complete proteome; Cytoplasm;
KW   Developmental protein; Differentiation; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    358       cAMP-dependent protein kinase catalytic
FT                                subunit PRKX.
FT                                /FTId=PRO_0000086582.
FT   DOMAIN       49    303       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   DOMAIN      304    358       AGC-kinase C-terminal.
FT   NP_BIND      55     63       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   ACT_SITE    172    172       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      78     78       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES       1      1       N-acetylmethionine.
FT                                {ECO:0000244|PubMed:22814378}.
FT   MOD_RES     203    203       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:Q922R0}.
FT   VARIANT      43     43       V -> A (in dbSNP:rs3752362).
FT                                /FTId=VAR_061744.
FT   MUTAGEN      78     78       K->R: Loss of function.
FT                                {ECO:0000269|PubMed:12082174}.
FT   MUTAGEN      93     93       H->Q: Constitutive kinase activity; when
FT                                associated with R-202.
FT                                {ECO:0000269|PubMed:16236808}.
FT   MUTAGEN     202    202       W->R: Constitutive kinase activity; when
FT                                associated with Q-93.
FT                                {ECO:0000269|PubMed:16236808}.
FT   MUTAGEN     283    283       R->L: Increases the affinity for PRKAR2A
FT                                and PRKAR2B.
FT                                {ECO:0000269|PubMed:20819953}.
SQ   SEQUENCE   358 AA;  40896 MW;  B603834E3541CB56 CRC64;
     MEAPGLAQAA AAESDSRKVA EETPDGAPAL CPSPEALSPE PPVYSLQDFD TLATVGTGTF
     GRVHLVKEKT AKHFFALKVM SIPDVIRLKQ EQHVHNEKSV LKEVSHPFLI RLFWTWHDER
     FLYMLMEYVP GGELFSYLRN RGRFSSTTGL FYSAEIICAI EYLHSKEIVY RDLKPENILL
     DRDGHIKLTD FGFAKKLVDR TWTLCGTPEY LAPEVIQSKG HGRAVDWWAL GILIFEMLSG
     FPPFFDDNPF GIYQKILAGK IDFPRHLDFH VKDLIKKLLV VDRTRRLGNM KNGANDVKHH
     RWFRSVDWEA VPQRKLKPPI VPKIAGDGDT SNFETYPEND WDTAAPVPQK DLEIFKNF
//
